0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Therapy Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
Published Date: October 2019
|
Report Code: 360I-Auto-1L31
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Gene Therapy Market Premium Insight Competitive News Feed Analysis Company Usability Profiles Market Sizing Forecasts to 2025

Global Gene Therapy Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

Code: 360I-Auto-1L31
Report
October 2019
140 Pages
360iResearch
Region: Global,
Description
Table of Content

The Global Gene Therapy Market is expected to grow from USD 1636.49 Millions in 2018 to USD 6436.64 Millions by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 21.60%.

 

"Significant way of treatment to eradicates the practice of surgery, drugs, or other procedures that lead to side effects on the health of individuals is one of the factors largely attributing to the growth of the Global Gene Therapy Market "

The factors attributing to the growth of the market are Significant way of treatment to eradicates the practice of surgery, drugs, or other procedures that lead to side effects on the health of individuals, Government support and ethical acceptance of gene therapy for cancer treatment, Application in the treatment of various diseases such as cancer, haemophilia, parkinson’s disease, and HIV, and Innovation in gene therapy for rare & cardiovascular diseases treatment coupled with the awareness regarding the ability of gene therapy. However, some factors such as High cost associated with gene therapies may hinder the market growth. The Global Gene Therapy Market is expected to showcase the opportunities such as Upsurge in a number of gene therapy treatment centers in developed countries, Increasing adoption for gene therapy for the oncological disorder, and Growing strategic alliances and ongoing research for orphan diseases. In the near future market may face the possible challenges in the growth due to Potential disorders associated with the immune response. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Global Gene Therapy Market.

 

On the basis of Type, the Global Gene Therapy Market is studied across Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy, Suicide Gene Therapy, and Tumor Suppressor Gene Therapy.

On the basis of Vector Type, the Global Gene Therapy Market is studied across Non-viral Vectors and Viral Vectors.

On the basis of Application, the Global Gene Therapy Market is studied across Cardiovascular Diseases, Genetic Diseases, Infectious Diseases, Neurological Diseases, and Oncological Disorders.

 

"Audentes Therapeutics the potential growing player for the Global Gene Therapy Market"

 

The key players profiled in the Global Gene Therapy Market are Audentes Therapeutics, Editas Medicine, Adaptimmune, Spark Therapeutics, Abeona Therapeutics, Inc.,, Bluebird bio, Inc., Merck & Co., Inc, Gilead, Achieve Life Sciences, Inc., Novartis, AGTC, Orchard Therapeutics, and Biogen.

In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

 

Research Methodology:

Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding obtained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

 

The report provides insights on the following pointers:

  1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Gene Therapy Market
  2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Gene Therapy Market
  3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Gene Therapy Market
  4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Gene Therapy Market
  5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Gene Therapy Market

 

The report answers questions such as:

  1. What is the market size of the Gene Therapy market in the Global?
  2. What are the factors that affect the growth in the Global Gene Therapy Market over the forecast period?
  3. What is the competitive position in the Global Gene Therapy Market?
  4. Which are the best product areas to be invested in over the forecast period in the Global Gene Therapy Market?
  5. What are the opportunities in the Global Gene Therapy Market?
  6. What are the modes of entering the Global Gene Therapy Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. Executive Summary
3.1. Outlook in the Gene Therapy Market
3.2. Opportunities in the Gene Therapy Market
3.3. Geographical Analysis in the Gene Therapy Market
4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Significant way of treatment to eradicates the practice of surgery, drugs, or other procedures that lead to side effects on the health of individuals
4.2.1.2. Innovation in gene therapy for rare & cardiovascular diseases treatment coupled with the awareness regarding the ability of gene therapy
4.2.1.3. Application in the treatment of various diseases such as cancer, haemophilia, parkinson’s disease, and HIV
4.2.1.4. Government support and ethical acceptance of gene therapy for cancer treatment
4.2.2. Restraints
4.2.2.1. High cost associated with the gene therapies
4.2.3. Opportunities
4.2.3.1. Upsurge in a number of gene therapy treatment centers in developed countries
4.2.3.2. Increasing adoption for gene therapy for the oncological disorder
4.2.3.3. Growing strategic alliances and ongoing research for orphan diseases
4.2.4. Challenges
4.2.4.1. Potential disorders associated with the immune response
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. Global Gene Therapy Market, by Type
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Antigen Gene Therapy
5.4. Cancer Gene Therapy
5.5. Cytokine Gene Therapy
5.6. Suicide Gene Therapy
5.7. Tumor Suppressor Gene Therapy
6. Global Gene Therapy Market, by Vector Type
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Non-viral Vectors
6.4. Viral Vectors
7. Global Gene Therapy Market, by Application
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Cardiovascular Diseases
7.4. Genetic Diseases
7.5. Infectious Diseases
7.6. Neurological Diseases
7.7. Oncological Disorders
8. Americas Gene Therapy Market Estimates & Trend Analysis
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Canada
8.4. Mexico
8.5. United States
9. Asia-Pacific Gene Therapy Market Estimates & Trend Analysis
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. China
9.4. India
9.5. Japan
10. Europe, Middle East & Africa Gene Therapy Market Estimates & Trend Analysis
10.1. Overview
10.2. Market Sizing & Forecasting
10.3. France
10.4. Germany
10.5. United Kingdom
11. Competitive Landscape
11.1. 360iResearch FPNV Positioning Matrix for Global Gene Therapy Market
11.2. Market Vendor Ranking Analysis for Global Gene Therapy Market
11.3. Competitive News Feed Analysis for Global Gene Therapy Market
12. Company Usability Profiles
12.1. Achieve Life Sciences, Inc.
12.1.1. Overview
12.1.2. Strategy
12.1.3. SWOT
12.1.4. Scorecard
12.2. Adaptimmune
12.2.1. Overview
12.2.2. Strategy
12.2.3. SWOT
12.2.4. Scorecard
12.3. Bluebird bio, Inc.
12.3.1. Overview
12.3.2. Strategy
12.3.3. SWOT
12.3.4. Scorecard
12.4. Gilead
12.4.1. Overview
12.4.2. Strategy
12.4.3. SWOT
12.4.4. Scorecard
12.5. Merck & Co., Inc
12.5.1. Overview
12.5.2. Strategy
12.5.3. SWOT
12.5.4. Scorecard
12.6. Abeona Therapeutics, Inc.,
12.6.1. Overview
12.6.2. Strategy
12.6.3. SWOT
12.6.4. Scorecard
12.7. AGTC
12.7.1. Overview
12.7.2. Strategy
12.7.3. SWOT
12.7.4. Scorecard
12.8. Audentes Therapeutics
12.8.1. Overview
12.8.2. Strategy
12.8.3. SWOT
12.8.4. Scorecard
12.9. Biogen
12.9.1. Overview
12.9.2. Strategy
12.9.3. SWOT
12.9.4. Scorecard
12.10. Editas Medicine
12.10.1. Overview
12.10.2. Strategy
12.10.3. SWOT
12.10.4. Scorecard
12.11. Novartis
12.11.1. Overview
12.11.2. Strategy
12.11.3. SWOT
12.11.4. Scorecard
12.12. Orchard Therapeutics
12.12.1. Overview
12.12.2. Strategy
12.12.3. SWOT
12.12.4. Scorecard
12.13. Spark Therapeutics
12.13.1. Overview
12.13.2. Strategy
12.13.3. SWOT
12.13.4. Scorecard
13. Appendix
13.1. Discussion Guide
13.2. Top Reports
13.2.1. Global Vaccine Contract Manufacturing Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.2. Global Stem Cells Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.3. Global Self-Checkout Systems Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.4. Global Passenger Security Systems Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.3. Author Details
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4499
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5499
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$6499
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD

RELATED REPORTS

Global Cytotoxicity Assay Market Size Status and Forecast 2021 2027
Global Cytotoxicity Assay Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-39V907
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Aquaculture Vaccine Market Size Status and Forecast 2021 2027
Global Aquaculture Vaccine Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-3I3192
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Intranasal Corticosteroids Market Size Status and Forecast 2021 2027
Global Intranasal Corticosteroids Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-25X2634
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Tumor Tracking System Market Size Status and Forecast 2021 2027
Global Tumor Tracking System Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-21F2812
Sun Jul 18 00:00:00 UTC 2021

Add to Cart